Skip to main content
SpringerLink
Log in

Perspectives on the Long Term Management of Heparin-Induced Thrombocytopenia

  • Published:
Journal of Thrombosis and Thrombolysis Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Warkentin TE, Kelton JG. Heparin-induced thrombo-cytopenia. Progr Hemost Thromb 1991;10:1–34.

    Google Scholar 

  2. Kapsch D, Silver D. Heparin-induced thrombocytopenia with thrombosis and hemorrhage. Arch Surg 1981;116:1423–1427.

    Google Scholar 

  3. Makhoul RG, Greenberg CS, McCann RL. Heparin-associated thrombocytopenia and thrombosis: a serious clinical problem and potential solution. J Vasc Surg 1986;4:522–528.

    Google Scholar 

  4. Cimo PL, et al. Heparin-induced thrombocytopenia: association with a platelet aggregating factor and arterial thromboses. Am J Hematol 1979;6:125–133.

    Google Scholar 

  5. Chang JC. White clot syndrome associated with heparin-induced thrombocytopenia: a review of 23 cases. Heart and Lung 1987;16:403–407.

    Google Scholar 

  6. King DJ, Kelton JG. Heparin-associated thrombocytopenia. Ann Intern Med 1984;100:535–540.

    Google Scholar 

  7. Warkentin TE, et al. Acute systemic reactions to intravenous bolus heparin therapy: characterization and relationship to heparin-induced thrombocytopenia. Blood 1992;80(suppl 1):160a.

    Google Scholar 

  8. Bell WR, Royall RM. Heparin-associated thrombocytopenia: a comparison of three heparin preparations. N Engl J Med 1980;303:902–907.

    Google Scholar 

  9. Gruel Y, et al. Fatal effect of re-exposure to heparin after previous heparin-associated thrombocytopenia and thrombosis. Lancet 1990;336:1077–1078.

    Google Scholar 

  10. Warkentin T, Chong B, Greinacher A. Heparin-induced thrombocytopenia: toward consensus. Thromb Haemostas 1998;79:1.

    Google Scholar 

  11. Laster J, et al. The heparin-induced thrombocytopenia syndrome: an update. Surgery 1987;102:763–770.

    Google Scholar 

  12. Laster J, Elfrink R, Silver D. Reexposure to heparin of patients with heparin-associated antibodies. J Vasc Surg 1989;9:677–682.

    Google Scholar 

  13. Olinger GN, et al. Cardiopulmonary bypass for patients with previously documented heparin-induced platelet aggregation. J Thorac Cardiovasc Surg 1984;87:673–677.

    Google Scholar 

  14. Matthies B, et al. Heparin-induced thrombocytopenia type II: reexposure to heparin. Dtsch Med Wochenschr (article in German) 1999;124: 1267–1270.

    Google Scholar 

  15. Kelton JG, et al. Clinical usefulness of testing for a heparin-dependent platelet-aggregating factor in patients with suspected heparin-associated thrombocytopenia. J Lab Clin Med 1984;103:606–612.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Coronary Care, Concord Hospital, Sydney, Australia

    David Brieger

Authors
  1. David Brieger
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Brieger, D. Perspectives on the Long Term Management of Heparin-Induced Thrombocytopenia. J Thromb Thrombolysis 10 (Suppl 1), 69–70 (2000). https://doi.org/10.1023/A:1027337405002

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1027337405002

Keywords

Search

Navigation